Disease Areas
News on disease research and therapeutic development trends in precision medicine.
Ibex AI-Driven Prostate Cancer Screening Test Nets FDA Clearance
Ibex Prostate Detect is designed to help pathologists catch small and rare cancers in whole-slide images from tissue biopsies that they might've missed.
Maze Therapeutics Doses First Patient in Phase II APOL1 Inhibitor Kidney Disease Trial
Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.
In Brief This Week: Ocugen, Acrivon, Myriad Genetics, Ariceum, Arbor Biotechnologies
News items for the week of Feb. 3, 2025.
Genomenon, Mirum Pharmaceuticals Partner for Rare Disease Data Sharing
Mirum has tapped Genomenon to produce a "landscape" of CYP27A1 gene variants to improve awareness and diagnosis of cerebrotendinous xanthomatosis.
AstraZeneca Optimistic About Phase III Camizestrant Data in 2025, Reports Strong Q4 Product Growth
Premium
If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.